COMBINATION THERAPY OF TUMOR-TARGETED IL-2 VARIANT IMMUNOCYTOKINES AND ANTIBODIES AGAINST HUMAN PD-L1

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG

发明人:

UMANA, PABLO,KLEIN, CHRISTIAN,NICOLINI, VALERIA G.

申请号：

SG11201701157U

公开号：

SG11201701157UA

申请日:

2015.08.25

申请国别(地区):

SG

年份:

2017

代理人:

摘要：

The present invention relates to the combination therapy of specific tumor-targeted IL-2 variant immunocytokines with specific antibodies which bind human PD-L1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/